Developing new drugs for the treatment of ocular diseases can be a time-consuming and costly undertaking. The trip from laboratory to market can take anywhere between 10 to 20 years and will cost around US$1 billion.
Create a free Member account at NZ Optics to read this article and more.
Inherited retinal disorders (IRDs) comprise a heterogeneous group of diseases characterised by diverse modes of inheritance, including autosomal dominant, autosomal recessive, X-linked (recessive and dominant), mitochondrial inheritance and less common patterns, such as pseudodominance. This genetic
Eye on Ophthalmology takes a look into alternatives to frequent intravitreal injections.
As primary eyecare providers, we are likely to come across many lesions in the periocular area. It is important to have a simple and systematic approach to dealing with these during examination.
Introduction Uveitis encompasses a diverse group of inflammatory disorders affecting the uveal tract (iris, ciliary body, choroid) and adjacent structures such as the retina, vitreous, and optic nerve
Submacular haemorrhage (SMH) is a vision-threatening complication most often seen in neovascular age-related macular degeneration (nAMD). Other causes include choroidal neovascular membranes secondary to pathological myopia; choroiditis; angioid streaks or choroidal rupture; retinal artery macro-ane
